The European Medicines Agency (EMEA) has recommended the withdrawal of the marketing authorisations for all lumiracoxib-containing medicines, because
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency (EMEA) has concluded that updated warnings to doctors and patients are needed to increase awareness of cases of suicida
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency (EMEA) has recommended updating the product information for rosiglitazone-containing antidiabetic medicines. Rosiglitaz
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended that new warnings be included in the product information for Sebivo (telbivudine), from N
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency (EMEA) has recommended that the product information of all centrally authorised angiotensin II receptor antagonists be harmonised, regarding their use during pregnancy.
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency has reviewed the risks associated with the use of heparin medicinal products contaminated with oversulphated chondroitin sulphate (OSCS). Heparins are used to prevent an
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new warning for their use in cancer patients stating that blood transfusi
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Finalising a review of the safety of moxifloxacin-containing medicines for oral use, the European Medicines Agency (EMEA) has concluded that these medicines should only be prescribed in the treatment
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended that the product information for Tysabri (natalizumab) be updated to further increase awareness
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Commission (EC), the European Medicines Agency (EMEA) and the United States Food and Drug Administration (FDA) have affirmed their commitment to regulatory cooperation and to intensifyin
read more » Discuss Add this link to...Bury Add to:
| Bookmarks